World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
39398
World Ranking
10348
National Ranking
5322

Overview

Naoto T. Ueno is affiliated with the University of Hawaiʻi Cancer Center in the United States. Their scientific work spans a broad range of topics primarily focused on oncology, cancer research, and molecular biology, with significant contributions to breast cancer treatment and related fields.

Their research covers several main fields of study, including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, their subfield expertise extends to:

  • Oncology
  • Cancer Research
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Radiology, Nuclear Medicine and Imaging

Key topics of Naoto T. Ueno's work include:

  • Breast Cancer Treatment Studies
  • HER2/EGFR in Cancer Research
  • Advanced Breast Cancer Therapies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Cells and Metastasis
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology

Publications by Naoto T. Ueno have appeared extensively in scientific journals, with frequent venues including:

  • Cancer Research
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Cancers
  • Clinical Cancer Research

Some of their recent scientific papers are:

  • "Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer," 2022, New England Journal of Medicine
  • "High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types," 2021, Annals of Oncology
  • "Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance," 2021, Nature Communications
  • "Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis," 2020, Cancer Research
  • "Body composition and breast cancer risk and treatment: mechanisms and impact," 2021, Breast Cancer Research and Treatment

Naoto T. Ueno collaborates frequently with several fellow researchers, including:

  • Debu Tripathy
  • Bora Lim
  • Wendy A. Woodward
  • Savitri Krishnamurthy
  • Jangsoon Lee

Best Publications

  • Landscape of somatic mutations in 560 breast cancer whole-genome sequences

    Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna

  • Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

    I F Khouri;M Keating;M Körbling;D Przepiorka

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

    Sergio Giralt;Peter F. Thall;Issa Khouri;Xuemei Wang

  • Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

    Hiroko Masuda;Keith A. Baggerly;Ying Wang;Ya Zhang

  • Bone Imaging in Metastatic Breast Cancer

    Tsuyoshi Hamaoka;John E. Madewell;Donald A. Podoloff;Gabriel N. Hortobagyi

  • Role of epidermal growth factor receptor in breast cancer

    Hiroko Masuda;Dongwei Zhang;Chandra Bartholomeusz;Hiroyoshi Doihara

  • High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.

    DJ McGrail;PG Pilié;NU Rashid;L Voorwerk

  • A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

    Christos Hatzis;Lajos Pusztai;Vicente Valero;Daniel J. Booser

  • International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

    S. Dawood;S. D. Merajver;P. Viens;P. B. Vermeulen

  • Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

    Marcos De Lima;Athanasios Anagnostopoulos;Mark Munsell;Munir Shahjahan

  • Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

    Naoki Niikura;Jun Liu;Naoki Hayashi;Elizabeth Ann Mittendorf

  • Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

    Funda Meric-Bernstam;Lauren Brusco;Kenna Shaw;Chacha Horombe

  • Inflammatory Breast Cancer: The Disease, the Biology, the Treatment

    Fredika M. Robertson;Melissa Bondy;Wei Yang;Hideko Yamauchi

  • Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

    Issa F Khouri;Peter McLaughlin;Rima M Saliba;Chitra Hosing

  • P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells

    Rita Nahta;Takeshi Takahashi;Naoto T. Ueno;Mien Chie Hung

  • Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center

    Naoto T. Ueno;Aman U. Buzdar;Sonja E. Singletary;Frederick C. Ames

  • Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint.

    Tamotsu Sudo;Masayuki Nitta;Hideyuki Saya;Naoto T. Ueno

  • Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation

    Donna Przepiorka;Donna Przepiorka;Terry L. Smith;Jody Folloder;Issa F Khouri

  • A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer

    Ankur K. Nagaraja;Chad J. Creighton;Zhifeng Yu;Huifeng Zhu

Frequent Co-Authors

Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Wendy A. Woodward
Wendy A. Woodward The University of Texas MD Anderson Cancer Center
Vicente Valero
Vicente Valero The University of Texas MD Anderson Cancer Center
James M. Reuben
James M. Reuben The University of Texas MD Anderson Cancer Center
Savitri Krishnamurthy
Savitri Krishnamurthy The University of Texas MD Anderson Cancer Center
Massimo Cristofanilli
Massimo Cristofanilli Cornell University
Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Anthony Lucci
Anthony Lucci The University of Texas MD Anderson Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Banu Arun
Banu Arun The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but want flexible or alternative pathways, several related online degrees can help you enter the healthcare field. For those looking to get started quickly, lpn programs offer a fast-track to become a licensed practical nurse, providing hands-on care in diverse medical settings.

Advancing your nursing qualifications can lead to specialized roles. For example, online psych np programs allow registered nurses to become Psychiatric-Mental Health Nurse Practitioners, a field growing in demand.

For those more interested in the business side of healthcare, a health administration degree online prepares you for leadership positions and helps you understand the complexities of managing medical organizations. Those seeking cost-effective options can explore the cheapest online master degree in healthcare administration to advance their careers without significant financial burden.

Each of these pathways offers flexible, accredited, and in-demand options for students looking to enter or grow in the healthcare sector—beyond traditional medical school routes.

Best Scientists Citing Naoto T. Ueno

Trending Scientists